Literature DB >> 3278589

Hypoxic vs septic pulmonary hypertension. Selective role of thromboxane mediation.

C Hammerman1, K Komar, H Abu-Khudair.   

Abstract

Pulmonary hypertension was generated in 11 newborn piglets, via either infusion of group B beta-hemolytic streptococci (n = 5) or induction of isocapnic hypoxia (n = 6), to study the contributions of thromboxane metabolite thromboxane B2 levels to different types of pulmonary hypertension. After 30 minutes of stable pulmonary hypertension, mean (+/- SD) pulmonary artery pressure increased similarly from 16 +/- 4 to 33 +/- 5 mm Hg (hypoxic), and from 14 +/- 2 to 34 +/- 6 mm Hg (septic). All other measured hemodynamic variables were similar. Despite these hemodynamic similarities, there were significant differences in thromboxane B2 levels. After 60 minutes of pulmonary hypertension, thromboxane B2 levels were 760 +/- 253 pg/mL (hypoxic), and 3103 +/- 1083 pg/mL (septic). These data demonstrate that, while thromboxane appears to be crucial in mediating septic pulmonary hypertension in the piglet, it is not associated with hypoxic pulmonary hypertension, implying that different types of pulmonary hypertension are probably mediated by different biochemical agents.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3278589     DOI: 10.1001/archpedi.1988.02150030093030

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  7 in total

Review 1.  Treatment of persistent pulmonary hypertension of the newborn: update.

Authors:  Y K Abu-Osba
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

Review 2.  Persistent pulmonary hypertension of the newborn: pathogenesis, etiology, and management.

Authors:  Enrique M Ostrea; Esterlita T Villanueva-Uy; Girija Natarajan; Herbert G Uy
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

3.  Endogenous formation of prostanoids in neonates with persistent pulmonary hypertension.

Authors:  P G Kühl; R B Cotton; H Schweer; H W Seyberth
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

4.  Milrinone attenuates thromboxane receptor-mediated hyperresponsiveness in hypoxic pulmonary arterial myocytes.

Authors:  K T Santhosh; O Elkhateeb; N Nolette; O Outbih; A J Halayko; S Dakshinamurti
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

5.  Variations in local PGE levels: a potential factor in therapeutic responsiveness?

Authors:  C Hammerman; R Arcilla; K C Bui
Journal:  Pediatr Cardiol       Date:  1991-04       Impact factor: 1.655

Review 6.  Molecular physiopathogenetic mechanisms and development of new potential therapeutic strategies in persistent pulmonary hypertension of the newborn.

Authors:  Giuseppe Distefano; Pietro Sciacca
Journal:  Ital J Pediatr       Date:  2015-02-08       Impact factor: 2.638

7.  Thromboxane promotes smooth muscle phenotype commitment but not remodeling of hypoxic neonatal pulmonary artery.

Authors:  Fabiana Postolow; Jena Fediuk; Nora Nolette; Martha Hinton; Shyamala Dakshinamurti
Journal:  Fibrogenesis Tissue Repair       Date:  2015-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.